Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study

被引:12
|
作者
Perveen, Shuhana [1 ]
Unwin, Danielle [1 ]
Shetty, Amith Loknath [1 ]
机构
[1] Westmead Hosp, Emergency Dept, Sydney, NSW 2145, Australia
关键词
D-dimer; Point of care systems; Pulmonary embolism; Bioequivalence; Length of stay; VENOUS THROMBOEMBOLISM; OUTPATIENTS; ACCURACY;
D O I
10.3343/alm.2013.33.1.34
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: D-dimer is used widely as a diagnostic aid in low- and moderate-risk patients with suspected venous thromboembolism (VTE). While our laboratory utilizes VIDAS D-dimer analyzer (bioMerieux SA, France), our emergency department (ED) recently procured a D-dimer analyzer AQT90 FLEX (Radiometer Medical ApS, Denmark) for point of care testing (FOOT) to facilitate patient management. We aimed to determine whether the time taken to receive D-dimer results using the 2 different analyzers differed significantly and to quantify the limits of agreement between the results of the 2 methods measured on the same patient. Methods: Adult patients presenting to the ED and requiring diagnostic workup for suspected VTE were included in this prospective observational study. Patients underwent simultaneous D-dimer measurements using the 2 different analyzers. Results: The paired results from 104 patients were analyzed. The median time for the D-dimer results from triage by VIDAS was 258 min (Inter-quartile range [IQR], 173-360) and by FOOT was 146 min (IQR, 55-280.5); the median time difference was 101.5 min (IQR, 82-125.5). On an average, FOOT D-dimer values were 15% lower on the same sample (limits of agreement, 34-213%). FOOT predicted 83% of VIDAS positive results (sensitivity, 83.3% [95% confidence interval (CI), 70.4-91.3%]; specificity, 100% [95% CI, 93.6-100%]). All patients with positive imaging were identified correctly by both methods. Conclusions: FOOT delivers D-dimer results in significantly shorter turnaround times than pathology services; however, poor bioequivalence between VIDAS and FOOT raises the issue of acceptability for use in the ED.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [31] Point-of-care testing for D-dimer in the exclusion of venous thromboembolism: a critical analysis
    Grand, Francois
    Blanc-Jouvan, Florence
    Delassasseigne, Celine
    Galinat, Hubert
    Roy, Pierre-Marie
    Talon, Laurie
    Toussaint-Hacquard, Marie
    Macchi, Laurent
    ANNALES DE BIOLOGIE CLINIQUE, 2023, 81 (05) : 461 - 474
  • [32] Provision of an external quality assessment programme for D-dimer point of care testing kits
    Kitchen, D.
    Munroe-Peart, S.
    Kitchen, S.
    Jennings, I
    Woods, T. A. L.
    Walker, I. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 605 - 605
  • [33] The introduction of a rapid ELISA D-dimer increases emergency department testing with no effect on the diagnosis of pulmonary embolism
    Kabrhel, C
    Matts, C
    McNamara, M
    Katz, J
    ANNALS OF EMERGENCY MEDICINE, 2005, 46 (03) : S11 - S11
  • [34] Augmenting D-dimer Testing for Pulmonary Embolism Rule-out in the Emergency Department With Artificial Intelligence
    Haimovich, A.
    Lopez, K.
    Forman, H.
    Kline, J.
    Venkatesh, A.
    Taylor, R.
    ANNALS OF EMERGENCY MEDICINE, 2022, 80 (04) : S29 - S30
  • [35] Point-of-Care Testing in the Emergency Department
    Workman, Chuck
    Wynn, Mollie
    Epperson, Ann
    POINT OF CARE, 2006, 5 (01): : 5 - 5
  • [36] The point-of-care testing in the emergency department
    Carraro, Paolo
    EMERGENCY CARE JOURNAL, 2019, 15 (02) : 46 - 50
  • [38] HIV point of care testing in the emergency department
    Noble, H.
    Wright, G.
    Young, E.
    HIV MEDICINE, 2012, 13 : 61 - 61
  • [39] VIDAS D-DIMER - A NEW SYSTEM FOR THE ASSAY OF D-DIMER IN EMERGENCY
    BRONNER, J
    DROUIN, B
    SARTRE, J
    DUPUY, G
    PITTET, JL
    LELOUARN, J
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1101 - 1101
  • [40] Point-of-Care Testing for D-Dimer in the Diagnosis of Venous Thromboembolism in Primary Care: A Narrative Review
    Christopher P. Price
    Matthew Fay
    Rogier M. Hopstaken
    Cardiology and Therapy, 2021, 10 : 27 - 40